Zacks.com on MSN4 小时
Wall Street Analysts See a 73.42% Upside in Kiniksa Pharmaceuticals (KNSA): Can the Stock ...
Kiniksa Pharmaceuticals, Ltd. (KNSA) closed the last trading session at $20.28, gaining 3.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...
来自MSN3 小时
Wall Street Analysts Predict a 228.87% Upside in Arvinas (ARVN): Here's What You Should Know
Arvinas, Inc. (ARVN) closed the last trading session at $17.70, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...
He died alone on A Bay Area street. Could these new treatment reforms have saved him?
A crime measure California voters approved in November gives repeat drug offenders the choice to enter treatment and have the ...